Evidence map›Paper›PMID 42384486›Full record

ArticleCell reports2026

Outer membrane remodeling via lipid-peptidoglycan crosstalk enables lipooligosaccharide-deficient colistin resistance.

Roberto Jhonatan Olea-Ozuna, Berenice Furlan, Hanling Gong, Orietta Massidda, Joseph M Boll

Abstract read
In one paragraph

Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Roberto Jhonatan Olea-OzunaDepartment of Biological Sciences, University of Texas at Dallas, Richardson, TX, USA.
Berenice FurlanDepartment of Biological Sciences, University of Texas at Dallas, Richardson, TX, USA; Center of Medical Sciences (CISMed), Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Hanling GongDepartment of Biological Sciences, University of Texas at Dallas, Richardson, TX, USA.
Orietta MassiddaCenter of Medical Sciences (CISMed), Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
Joseph M BollDepartment of Biological Sciences, University of Texas at Dallas, Richardson, TX, USA. Electronic address: joseph.boll@utdallas.edu.

Funding

Mechanistic basis of how LD-transpeptidases protect against outer membranedefectsR01AI168159 · NIAID · UNIVERSITY OF TEXAS DALLAS · PI Joseph Michael Boll · 2022 to 2026
$2.3M
Reinforcing the barrier: Understanding how cell envelope modifications promote intrinsic antimicrobial tolerance and resistance in Acinetobacter baumanniiR35GM143053 · NIGMS · UNIVERSITY OF TEXAS DALLAS · PI BOLL, JOSEPH MICHAEL · 2021 to 2025
$1.9M
NIAID NIH HHS R01 AI168159NIGMS NIH HHS R35 GM143053
6 · The paper itself

Abstract

Gram-negative bacteria rely on an asymmetric outer membrane for barrier integrity, with phospholipids confined to the inner leaflet and lipopolysaccharide or lipooligosaccharide (LOS) forming the outer leaflet. Although these glycolipids were long considered essential, recent findings challenge this view. Here, using Acinetobacter baumannii, we identify lipid asymmetry as a structural checkpoint controlling access to LOS-independent survival. Disruption of phospholipid transport and degradation destabilizes membrane balance, creating a permissive state that enables the emergence of LOS-deficient, colistin-resistant variants. Lipidomic and transcriptomic analyses reveal coordinated envelope remodeling, including altered peptidoglycan synthesis and enhanced envelope trafficking. Loss of LOS coincides with repression of PBP1A, and maintaining its activity blocks adaptation. We propose a three-state model-basal, permissive, and adapted-that explains how envelope architecture governs antibiotic resistance and membrane remodeling.

Indexed as

Acinetobacter baumanniiBacterial Outer MembraneColistinDrug Resistance, BacterialLipopolysaccharidesPeptidoglycanColistinlipid-linked oligosaccharidesLipopolysaccharidesPeptidoglycancolistin resistanceCP: cell biologyCP: microbiologyGram-negative bacterialipid asymmetrylipooligosaccharide deficiencyLOSMla pathwayouter membranepeptidoglycan remodelingPldA phospholipaseTol-Pal complex

Identifiers

PMID42384486
PMCPMC13470916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.